University of Minnesota. Driven to Discover.
In household contacts, 14% who got a placebo developed flu, compared with 2% in the baloxavir group.
Japanese researchers describe two H3N2 flu viruses with mutations that may increase antiviral resistance.
Baloxavir reduced flu symptoms by 1 day and reduced viral shedding.
Sort Results By:
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.